Immediate and delayed effects of mammographic screening on breast cancer mortality and incidence in birth cohorts

British Journal of Cancer

Volumn 109, Issue 9, 2013, Pages 2467-2471

  Ripping, T M ^a   Verbeek, A L M ^a,b   Van Der Waal, D ^a   Otten, J D M ^a   Den Heeten, G J ^b,c   Fracheboud, J ^d   De Koning, H J ^d   Broeders, M J M ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b National Expert and Training Centre for Breast Cancer Screening   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

birth cohort; incidence; mammographic screening; mortality; The Netherlands

Indexed keywords

ADULT; AGED; ARTICLE; BIRTH; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NETHERLANDS; PRIORITY JOURNAL;

EID: 84887017793     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.627     Document Type: Article

References (28)

1. Ascunce EN, Moreno-Iribas C, Urtiaga AB, Ardanaz E, Sanz ME, Castilla J, Egüés N (2007) Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme. J Med Screen 14(1): 14-20.
2. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JDF, Feuer EJ (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17): 1784-1792.
3. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ (2000) Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: Comparison of observed with predicted mortality. Br Med J 321(7262): 665.
4. Boer R, Warmerdam P, De Koning H, Van Oortmarssen G (1994) Extra incidence caused by mammographic screening. Lancet 343(8903): 979.
5. Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Poop E, Massat N, Duffy S, Lynge E, Paci E. Euroscreen Working Group (2012) The impact of mammographic screening on breast cancer mortality in Europe: A review of observational studies. J Med Screen 19: 14-25.
6. Brown SBF, Morrison DS, Cooke TG (2009) Increasing incidence of breast cancer: Distinguishing between the effects of birth cohort and a national breast screening programme. Breast Cancer Res Treat 116(3): 603-607.
7. Centraal Bureau voor de Statistiek (2012) Available atstatline.cbs.nl (accessed: 18 June 2012). Clayton D, Schifflers E (1987a) Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 6(4): 449-467.
8. Clayton D, Schifflers E (1987b) Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 6(4): 469-481.
9. Colbert JA, Adler JN (2013) Clinical decisions. Mammography screening- polling results. N Engl J Med 368(9): E12.
10. De Gelder R (2012) Predicting the Benefits and Harms of Breast Cancer Screening: Current Debates and Future Directions (Doctoral). Erasmus University: Rotterdam.
11. De Gelder R, Heijnsdijk EAM, Van Ravesteyn NT, Fracheboud J, Draisma G, De Koning HJ (2011) Interpreting overdiagnosis estimates in populationbased mammography screening. Epidemiol Rev 33(1): 111-121.
12. Haukka J, Byrnes G, Boniol M, Autier P (2011) Trends in breast cancer mortality in Sweden before and after implementation of mammography screening. PLoS One 6(9): E22422.
13. Holford TR (1991) Understanding the effects of age, period, and cohort on incidence and mortality-rates. Annu Rev Public Health 12: 425-457.
14. Integraal kankercentrum Nederland (2012) Available at www.cijfersover kanker.nl (accessed: 18 June 2012)
15. Junod B, Zahl PH, Kaplan RM, Olsen J, Greenland S (2011) An investigation of the apparent breast cancer epidemic in France: Screening and incidence trends in birth cohorts. BMC Cancer 11(401).
16. Martinez-Alonso M, Vilaprinyo E, Marcos-Gragera R, Rue M (2010) Breast cancer incidence and overdiagnosis in Catalonia (Spain). Breast Cancer Res 12(4): R58.
17. Moss SM, Nystrom L, Jonsson H, Paci E, Lynge E, Njor S, Broeders M. Euroscreen Working Group (2012) The impact of mammographic screening on breast cancer mortality in Europe: A review of trend studies. J Med Screen 19: 26-32.
18. Mukhtar TK, Yeates DR, Goldacre MJ (2013) Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: Population-based study. J R Soc Med 106(6): 234-242.
19. National Evaluation Team for Breast Cancer Screening (2009) National Evaluation of Breast Cancer Screening in The Netherlands. 1990-2007 (XII). Twelfth Evaluation Report. Erasmus MC: Rotterdam.
20. National Evaluation Team for Breast Cancer Screening (2012) Main Results 2010 Breast Cancer Screening Programme in The Netherlands. Erasmus MC: Rotterdam.
21. Njor SH, Olsen AH, Blichert-Toft M, Schwartz W, Vejborg I, Lynge E (2013) Overdiagnosis in screening mammography in Denmark: Population based cohort study. BMJ 346: F1064.
22. Otten JDM, Broeders MJM, Fracheboud J, Otto SJ, De KoningHJ, Verbeek ALM (2008) Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006. Int J Cancer 123(8): 1929-1934.
23. Pollán M, MichelenaMJ, Ardanaz E, Izquierdo A, Sánchez-Pérez MJ, Torrella A, Vicente Argüelles-Suárez M, Borràs J, Franch P, Jiménez R, Navarro C, Rabanaque MJ, Ramírez C, Rojas MD, Sáinz-Miranda M (2010) Breast cancer incidence in Spain before, during and after the implementation of screening programmes. Ann Oncol 21(Suppl 3): Iii97-iii102.
24. Puliti D, Miccinesi G, Paci E (2011) Overdiagnosis in breast cancer: Design and methods of estimation in observational studies. Prevent Med 53(3): 131-133.
25. Svendsen AL, Olsen AH, Von Euler-Chelpin M, Lynge E (2006) Breast cancer incidence after the introduction of mammography screening: What should be expected?. Cancer 106(9): 1883-1890.
26. Tarone RE, Chu KC (1992) Implications of birth cohort patterns in interpreting trends in breast cancer rates. J Natl Cancer Inst 84(18): 1402-1410.
27. Vervoort MM, Draisma G, Fracheboud J, van de Poll-Franse LV, de Koning HJ (2004) Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 91(2): 242-247.
28. Viel JF, Rymzhanova R, Fournier E, Danzon A (2011) Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: An age-period-cohort analysis. Cancer Epidemiol 35(6): 521-525